Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Maryam Mirahmad, Reyhaneh Sabourian, Mohammad Mahdavi, Bagher Larijani & Maliheh Safavi. (2022) In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation. Drug Metabolism Reviews 54:2, pages 161-193.
Read now
Read now
Zsolt Safar, Emese Kis, Franciska Erdo, Joseph K Zolnerciks & Peter Krajcsi. (2019) ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors. Expert Opinion on Drug Metabolism & Toxicology 15:4, pages 313-328.
Read now
Read now
Abhirup Mandal, Vibhuti Agrahari, Varun Khurana, Dhananjay Pal & Ashim K. Mitra. (2017) Transporter effects on cell permeability in drug delivery. Expert Opinion on Drug Delivery 14:3, pages 385-401.
Read now
Read now
R. J. Riley, S. A. Foley, P. Barton, M. G. Soars & B. Williamson. (2016) Hepatic drug transporters: the journey so far. Expert Opinion on Drug Metabolism & Toxicology 12:2, pages 201-216.
Read now
Read now
Donna A. Volpe. (2016) Transporter assays as useful in vitro tools in drug discovery and development. Expert Opinion on Drug Discovery 11:1, pages 91-103.
Read now
Read now
Péter Krajcsi, Márton Jani, Beáta Tóth, Franciska Erdő, Emese Kis, Erzsébet Beéry & István Sziráki. (2012) Efflux transporters in the blood–brain interfaces – in vitro and in vivo methods and correlations. Expert Opinion on Drug Metabolism & Toxicology 8:4, pages 419-431.
Read now
Read now
Katherine S. Fenner, Hannah M. Jones, Mohammed Ullah, Sarah Kempshall, Maurice Dickins, Yurong Lai, Paul Morgan & Hugh A. Barton. (2012) The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance. Xenobiotica 42:1, pages 28-45.
Read now
Read now
Robert Elsby, Veronica Smith, Lisa Fox, David Stresser, Caroline Butters, Pradeep Sharma & Dominic D. Surry. (2011) Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug–drug interaction to support regulatory submissions. Xenobiotica 41:9, pages 764-783.
Read now
Read now
Katalin Jemnitz, Krisztina Heredi-Szabo, Judit Janossy, Eniko Ioja, Laszlo Vereczkey & Peter Krajcsi. (2010) ABCC2/Abcc2: a multispecific transporter with dominant excretory functions. Drug Metabolism Reviews 42:3, pages 402-436.
Read now
Read now
Articles from other publishers (72)
Kexin Lin, Xiaorui Kong, Xufeng Tao, Xiaohan Zhai, Linlin Lv, Deshi Dong, Shilei Yang & Yanna Zhu. (2023) Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters. Molecules 28:13, pages 5252.
Crossref
Crossref
Tomohisa Iinuma, Syuji Yonekura, Kiyoshi Hirahara, Junya Kurita, Riyo Yoneda, Tomoyuki Arai, Yuri Sonobe, Rie Shinmi, Yoshitaka Okamoto & Toyoyuki Hanazawa. (2023) Differences in the expression of multidrug resistance proteins in chronic rhinosinusitis according to endotype. Allergology International.
Crossref
Crossref
Andrzej Łach, Agnieszka Wnuk & Anna Katarzyna Wójtowicz. (2023) Experimental Models to Study the Functions of the Blood–Brain Barrier. Bioengineering 10:5, pages 519.
Crossref
Crossref
Laura Goetzl, Nune Darbinian, Nana Merabova, Lindsay C. Devane & Sammanda Ramamoorthy. (2022) Gestational Age Variation in Human Placental Drug Transporters. Frontiers in Pharmacology 13.
Crossref
Crossref
Yusuke Masuo, Azusa Futatsugi & Yukio Kato. 2022. Drug Transporters. Drug Transporters
413
431
.
Mary Ann Moran, Elizabeth B. Kujawinski, William F. Schroer, Shady A. Amin, Nicholas R. Bates, Erin M. Bertrand, Rogier Braakman, C. Titus Brown, Markus W. Covert, Scott C. Doney, Sonya T. Dyhrman, Arthur S. Edison, A. Murat Eren, Naomi M. Levine, Liang Li, Avena C. Ross, Mak A. Saito, Alyson E. Santoro, Daniel Segrè, Ashley Shade, Matthew B. Sullivan & Assaf Vardi. (2022) Microbial metabolites in the marine carbon cycle. Nature Microbiology 7:4, pages 508-523.
Crossref
Crossref
Sukanya Roy, Priyanka Banerjee, Burcin Ekser, Kayla Bayless, David Zawieja, Gianfranco Alpini, Shannon S. Glaser & Sanjukta Chakraborty. (2021) Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer. The American Journal of Pathology 191:12, pages 2052-2063.
Crossref
Crossref
Chen Ning, Shengdi Su, Jiaming Li, Dexuan Kong, Hui Cai, Zhiying Qin, Han Xing, Xijing Chen & Jiake He. (2021) Evaluation of a Clinically Relevant Drug–Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity. Frontiers in Pharmacology 12.
Crossref
Crossref
William A. Murphy, Chitra Saran, Paavo Honkakoski & Kim L.R. Brouwer. 2021. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity
261
306
.
Sara Abdelfatah, Madeleine Böckers, Maitane Asensio, Onat Kadioglu, Anette Klinger, Edmond Fleischer & Thomas Efferth. (2021) Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells. Phytomedicine 86, pages 153196.
Crossref
Crossref
Bruno Stieger, Julia Steiger & Kaspar P. Locher. (2021) Membrane lipids and transporter function. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1867:5, pages 166079.
Crossref
Crossref
Nihan Izat & Selma Sahin. (2021) Hepatic transporter‐mediated pharmacokinetic drug–drug interactions: Recent studies and regulatory recommendations. Biopharmaceutics & Drug Disposition 42:2-3, pages 45-77.
Crossref
Crossref
Flavia Bieczynski, Kathleen Burkhardt‐Medicke, Carlos M. Luquet, Stefan Scholz & Till Luckenbach. (2020) Chemical effects on dye efflux activity in live zebrafish embryos and on zebrafish Abcb4 ATPase activity. FEBS Letters 595:6, pages 828-843.
Crossref
Crossref
Yuqi Yang, Zhuo-Xun Wu, Jing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, Sabrina Lusvarghi, Suresh V. Ambudkar, Zhe-Sheng Chen & Dong-Hua Yang. (2021) OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance. Frontiers in Pharmacology 12.
Crossref
Crossref
Zsolt Sáfár, Gábor Kecskeméti, Judit Molnár, Anita Kurunczi, Zoltán Szabó, Tamás Janáky, Emese Kis & Péter Krajcsi. (2021) Inhibition of ABCG2/BCRP-mediated transport–correlation analysis of various expression systems and probe substrates. European Journal of Pharmaceutical Sciences 156, pages 105593.
Crossref
Crossref
Jing-Quan Wang, Yuqi Yang, Chao-Yun Cai, Qiu-Xu Teng, Qingbin Cui, Jun Lin, Yehuda G. Assaraf & Zhe-Sheng Chen. (2021) Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance. Drug Resistance Updates 54, pages 100743.
Crossref
Crossref
Shruti Surendran, Pooja Dhurjad & Satheeshkumar Nanjappan. 2021. Evidence Based Validation of Traditional Medicines. Evidence Based Validation of Traditional Medicines
469
494
.
Priyanka R. Kulkarni, Amir S. Youssef & Aneesh A. Argikar. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
369
417
.
Sascha C.T. Nicklisch & Amro Hamdoun. (2020) Disruption of small molecule transporter systems by Transporter‐Interfering Chemicals (TICs). FEBS Letters 594:23, pages 4158-4185.
Crossref
Crossref
Luisa Möhle, Barbora Schwarzová, Markus Krohn, Sven Marcel Stefan & Jens Pahnke. (2020) Using a qPCR device to screen for modulators of ABC transporter activity: A step-by-step protocol. Journal of Pharmacological and Toxicological Methods 104, pages 106882.
Crossref
Crossref
Winfried Neuhaus. 2021. Organotypic Models in Drug Development. Organotypic Models in Drug Development
75
110
.
Jose J. G. Marin, Elisa Herraez, Elisa Lozano, Rocio I. R. Macias & Oscar Briz. (2019) Models for Understanding Resistance to Chemotherapy in Liver Cancer. Cancers 11:11, pages 1677.
Crossref
Crossref
Noora Sjöstedt, Tiina A. Salminen & Heidi Kidron. (2019) Endogenous, cholesterol-activated ATP-dependent transport in membrane vesicles from Spodoptera frugiperda cells. European Journal of Pharmaceutical Sciences 137, pages 104963.
Crossref
Crossref
Yoo-Kyung Song, Ji Eun Park, Yunseok Oh, Sungwoo Hyung, Yoo-Seong Jeong, Min-Soo Kim, Wooin Lee & Suk-Jae Chung. (2019) Suppression of Canine ATP Binding Cassette ABCB1 in Madin-Darby Canine Kidney Type II Cells Unmasks Human ABCG2-Mediated Efflux of Olaparib. Journal of Pharmacology and Experimental Therapeutics 368:1, pages 79-87.
Crossref
Crossref
Marjan Afrouzian, Rabab Al-Lahham, Svetlana Patrikeeva, Meixiang Xu, Valentina Fokina, Wayne G. Fischer, Sherif Z. Abdel-Rahman, Maged Costantine, Mahmoud S. Ahmed & Tatiana Nanovskaya. (2018) Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin. Biochemical Pharmacology 156, pages 467-478.
Crossref
Crossref
Iva Guberović, Marko Marjanović, Marija Mioč, Katja Ester, Irena Martin-Kleiner, Tatjana Šumanovac Ramljak, Kata Mlinarić-Majerski & Marijeta Kralj. (2018) Crown ethers reverse P-glycoprotein-mediated multidrug resistance in cancer cells. Scientific Reports 8:1.
Crossref
Crossref
Yan Zhang. (2018) Overview of Transporters in Pharmacokinetics and Drug Discovery. Current Protocols in Pharmacology 82:1, pages e46.
Crossref
Crossref
Mariline Gameiro, Renata Silva, Carolina Rocha-Pereira, Helena Carmo, Félix Carvalho, Maria Bastos & Fernando Remião. (2017) Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP. Molecules 22:4, pages 600.
Crossref
Crossref
Feng Deng, Noora Sjöstedt & Heidi Kidron. (2016) The Effect of Albumin on MRP2 and BCRP in the Vesicular Transport Assay. PLOS ONE 11:10, pages e0163886.
Crossref
Crossref
Lu Xiao, Tao Yi, Min Chen, Christopher Wai Kei Lam & Hua Zhou. (2016) A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP. European Journal of Pharmaceutical Sciences 93, pages 456-467.
Crossref
Crossref
Daniel Scotcher, Christopher Jones, Maria Posada, Amin Rostami-Hodjegan & Aleksandra Galetin. (2016) Key to Opening Kidney for In Vitro–In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data. The AAPS Journal 18:5, pages 1067-1081.
Crossref
Crossref
Tina Trdan Lušin, Aleš Mrhar, Bruno Stieger, Albin Kristl, Katja Berginc & Jurij Trontelj. (2015) Efflux and uptake transporters involved in the disposition of bazedoxifene. European Journal of Drug Metabolism and Pharmacokinetics 41:3, pages 251-257.
Crossref
Crossref
Gaurav Raj Dwivedi, Nimisha Tiwari, Aastha Singh, Akhil Kumar, Sudeep Roy, Arvind Singh Negi, Anirban Pal, Debabrata Chanda, Ashok Sharma & Mahendra P. Darokar. (2015) Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli. Applied Microbiology and Biotechnology 100:5, pages 2311-2325.
Crossref
Crossref
Gaurav Raj Dwivedi, Shikha Gupta, Anupam Maurya, Shubhandra Tripathi, Ashok Sharma, Mahendra P. Darokar & Santosh K. Srivastava. (2015)
Synergy Potential of Indole Alkaloids and Its Derivative against Drug-resistant
Escherichia coli
. Chemical Biology & Drug Design 86:6, pages 1471-1481.
Crossref
Crossref
S. Schadt, S. Simon, S. Kustermann, F. Boess, C. McGinnis, A. Brink, R. Lieven, S. Fowler, K. Youdim, M. Ullah, M. Marschmann, C. Zihlmann, Y.M. Siegrist, A.C. Cascais, E. Di Lenarda, E. Durr, N. Schaub, X. Ang, V. Starke, T. Singer, R. Alvarez-Sanchez, A.B. Roth, F. Schuler & C. Funk. (2015) Minimizing DILI risk in drug discovery — A screening tool for drug candidates. Toxicology in Vitro 30:1, pages 429-437.
Crossref
Crossref
Daniela Cihalova, Martina Ceckova, Radim Kucera, Jiri Klimes & Frantisek Staud. (2015) Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro. Biochemical Pharmacology 98:3, pages 465-472.
Crossref
Crossref
Wan Li, Hua Sun, Xingwang Zhang, Huan Wang & Baojian Wu. (2015) Efflux transport of chrysin and apigenin sulfates in HEK293 cells overexpressing SULT1A3: The role of multidrug resistance-associated protein 4 (MRP4/ABCC4). Biochemical Pharmacology 98:1, pages 203-214.
Crossref
Crossref
Gaurav Raj Dwivedi, Anupam Maurya, Dharmendra Kumar Yadav, Feroz Khan, Mahendra P. Darokar & Santosh Kumar Srivastava. (2015)
Drug Resistance Reversal Potential of Ursolic Acid Derivatives against Nalidixic Acid- and Multidrug-resistant
Escherichia coli
. Chemical Biology & Drug Design 86:3, pages 272-283.
Crossref
Crossref
Khine Myint, Yan Li, James Paxton & Mark McKeage. (2015) Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles. PLOS ONE 10:7, pages e0130727.
Crossref
Crossref
Balázs Magda, Zoltán Márta, Tímea Imre, Bernadett Kalapos-Kovács, Imre Klebovich, Jenő Fekete & Pál T. Szabó. (2015) Unexpected retention behavior of baicalin: Hydrophilic interaction like properties of a reversed-phase column. Journal of Pharmaceutical and Biomedical Analysis 111, pages 119-125.
Crossref
Crossref
Daniela Cihalova, Frantisek Staud & Martina Ceckova. (2015) Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro. Cancer Chemotherapy and Pharmacology 76:1, pages 105-116.
Crossref
Crossref
Marta Capannolo, Irene Fasciani, Stefania Romeo, Gabriella Aloisi, Mario Rossi, Pierangelo Bellio, Giuseppe Celenza, Benedetta Cinque, Maria Grazia Cifone, Marco Scarselli & Roberto Maggio. (2015) The atypical antipsychotic clozapine selectively inhibits interleukin 8 (IL-8)-induced neutrophil chemotaxis. European Neuropsychopharmacology 25:3, pages 413-424.
Crossref
Crossref
Christopher A. Palmiotti, Shikha Prasad, Pooja Naik, Kaisar M. D. Abul, Ravi K. Sajja, Anilkumar H. Achyuta & Luca Cucullo. (2014) In Vitro Cerebrovascular Modeling in the 21st Century: Current and Prospective Technologies. Pharmaceutical Research 31:12, pages 3229-3250.
Crossref
Crossref
Márton Jani & Péter Krajcsi. (2014) In vitro methods in drug transporter interaction assessment. Drug Discovery Today: Technologies 12, pages e105-e112.
Crossref
Crossref
Márton Jani, Csilla Ambrus, Rémi Magnan, Katalin Tauberné Jakab, Erzsébet Beéry, Joseph K. Zolnerciks & Péter Krajcsi. (2014) Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics. Archives of Toxicology 88:6, pages 1205-1248.
Crossref
Crossref
Tina Ritschel, Susanne M. A. Hermans, Marieke Schreurs, Jeroen J. M. W. van den Heuvel, Jan B. Koenderink, Rick Greupink & Frans G. M. Russel. (2014)
In Silico
Identification and
in Vitro
Validation of Potential Cholestatic Compounds through 3D Ligand-Based Pharmacophore Modeling of BSEP Inhibitors
. Chemical Research in Toxicology 27:5, pages 873-881.
Crossref
Crossref
Gaurav R. Dwivedi, Harish C. Upadhyay, Dharmendra K. Yadav, Vigyasa Singh, Santosh K. Srivastava, Feroz Khan, Nandan S. Darmwal & Mahendra P. Darokar. (2014)
4-Hydroxy-
α
-Tetralone and its Derivative as Drug Resistance Reversal Agents in Multi Drug Resistant
E
scherichia coli
. Chemical Biology & Drug Design 83:4, pages 482-492.
Crossref
Crossref
Wannes Dermauw & Thomas Van Leeuwen. (2014) The ABC gene family in arthropods: Comparative genomics and role in insecticide transport and resistance. Insect Biochemistry and Molecular Biology 45, pages 89-110.
Crossref
Crossref
Kee W. Tan, Daniel P. Killeen, Yan Li, James W. Paxton, Nigel P. Birch & Arjan Scheepens. (2014) Dietary polyacetylenes of the falcarinol type are inhibitors of breast cancer resistance protein (BCRP/ABCG2). European Journal of Pharmacology 723, pages 346-352.
Crossref
Crossref
Noora Sjöstedt, Hanna Kortejärvi, Heidi Kidron, Kati-Sisko Vellonen, Arto Urtti & Marjo Yliperttula. (2013) Challenges of Using In Vitro Data for Modeling P-Glycoprotein Efflux in the Blood-Brain Barrier. Pharmaceutical Research 31:1, pages 1-19.
Crossref
Crossref
Ravindra Varma Alluri, Peter Ward, Jeevan R. Kunta, Brian C. Ferslew, Dhiren R. Thakker & Shannon Dallas. 2014. Optimization in Drug Discovery. Optimization in Drug Discovery
369
404
.
Elizabeth J. Tarling, Thomas Q. de Aguiar Vallim & Peter A. Edwards. (2013) Role of ABC transporters in lipid transport and human disease. Trends in Endocrinology & Metabolism 24:7, pages 342-350.
Crossref
Crossref
Krisztina Herédi-Szabó, Johan E. Palm, Tommy B. Andersson, Ákos Pál, Dóra Méhn, Zsolt Fekete, Erzsébet Beéry, Katalin Tauberné Jakab, Márton Jani & Peter Krajcsi. (2013) A P-gp vesicular transport inhibition assay – Optimization and validation for drug–drug interaction testing. European Journal of Pharmaceutical Sciences 49:4, pages 773-781.
Crossref
Crossref
Anupam Maurya, Gaurav R. Dwivedi, Mahendra P. Darokar & Santosh K. Srivastava. (2013)
Antibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid-Resistant
Escherichia coli
. Chemical Biology & Drug Design 81:4, pages 484-490.
Crossref
Crossref
Kenta YoshidaKazuya MaedaYuichi Sugiyama. (2013) Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetic Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms. Annual Review of Pharmacology and Toxicology 53:1, pages 581-612.
Crossref
Crossref
Peter Krajcsi. (2013) Drug-transporter interaction testing in drug discovery and development. World Journal of Pharmacology 2:1, pages 35.
Crossref
Crossref
Per Artursson, Pär Matsson & Maria Karlgren. 2013. Transporters in Drug Development. Transporters in Drug Development
37
65
.
Krisztina Herédi‐Szabó, Emese Kis & Peter Krajcsi. (2012) The Vesicular Transport Assay: Validated In Vitro Methods to Study Drug‐Mediated Inhibition of Canalicular Efflux Transporters ABCB11/BSEP and ABCC2/MRP2. Current Protocols in Toxicology 54:1.
Crossref
Crossref
Alexander V. LyubimovJasminder Sahi, Cornelia Smith, LaHoma Easterwood, Susan Grepper & Edward LeCluyse. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
53
.
Alexander V. LyubimovJasminder Sahi, Yurong Lai & Caroline Lee. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
51
.
Julio C. Davila & Jose E. Manautou. (2012) Drug Transporters. Current Protocols in Toxicology 52:1.
Crossref
Crossref
Imad Hanna & Ryan M. Pelis. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
29
54
.
Suneet Shukla, Candice Schwartz, Khyati Kapoor, Abdul Kouanda & Suresh V. Ambudkar. (2012) Use of Baculovirus BacMam Vectors for Expression of ABC Drug Transporters in Mammalian Cells. Drug Metabolism and Disposition 40:2, pages 304-312.
Crossref
Crossref
Alexander V. LyubimovTonika Bohnert & Chandra Prakash. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
42
.
Annie Lumen, Deborah Silverman, Esteban Martinez, Zeba Ahmed, Deep Agnani, Poulomi Acharya & Joe Bentz. 2011. The Structure of Biological Membranes, Third Edition. The Structure of Biological Membranes, Third Edition
241
272
.
Steven W. Louie & Magang Shou. 2011. Mass Spectrometry in Drug Metabolism and Disposition. Mass Spectrometry in Drug Metabolism and Disposition
83
149
.
Péter Szerémy, Ákos Pál, Dóra Méhn, Beáta Tóth, Ferenc Fülöp, Péter Krajcsi & Krisztina Herédi-Szabó. (2011) Comparison of 3 Assay Systems Using a Common Probe Substrate, Calcein AM, for Studying P-gp Using a Selected Set of Compounds. SLAS Discovery 16:1, pages 112-119.
Crossref
Crossref
Dietmar Weitz. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
251
264
.
Nick Plant. 2011. Understanding the Dynamics of Biological Systems. Understanding the Dynamics of Biological Systems
59
82
.
Johan E. Karlsson, Catherine Heddle, Aleksei Rozkov, Joke Rotticci-Mulder, Ola Tuvesson, Constanze Hilgendorf & Tommy B. Andersson. (2010) High-Activity P-Glycoprotein, Multidrug Resistance Protein 2, and Breast Cancer Resistance Protein Membrane Vesicles Prepared from Transiently Transfected Human Embryonic Kidney 293-Epstein-Barr Virus Nuclear Antigen Cells. Drug Metabolism and Disposition 38:4, pages 705-714.
Crossref
Crossref
Annie Albin Lumen, Poulomi Acharya, Joseph W. Polli, Andrew Ayrton, Harma Ellens & Joe Bentz. (2010)
If the
K
I
Is Defined by the Free Energy of Binding to P-Glycoprotein, Which Kinetic Parameters Define the IC
50
for the Madin-Darby Canine Kidney II Cell Line Overexpressing Human Multidrug Resistance 1 Confluent Cell Monolayer?
. Drug Metabolism and Disposition 38:2, pages 260-269.
Crossref
Crossref
Kelly Bleasby, Xiaoyan Chu & Raymond Evers. 2010. Enzyme- and Transporter-Based Drug-Drug Interactions. Enzyme- and Transporter-Based Drug-Drug Interactions
237
255
.